Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults
- 19 April 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 76 (16), 1395-1402
- https://doi.org/10.1212/wnl.0b013e3182166e96
Abstract
Objective: Since Alzheimer disease (AD) neuropathology is thought to develop years before dementia, it may be possible to detect subtle AD-related atrophy in preclinical AD. Here we hypothesized that the “disease signature” of AD-related cortical thinning, previously identified in patients with mild AD dementia, would be useful as a biomarker to detect anatomic abnormalities consistent with AD in cognitively normal (CN) adults who develop AD dementia after longitudinal follow-up. Methods: We studied 2 independent samples of adults who were CN when scanned. In sample 1, 8 individuals developing AD dementia (CN-AD converters) after an average of 11.1 years were compared to 25 individuals who remained CN (CN-stable). In sample 2, 7 CN-AD converters (average follow-up 7.1 years) were compared to 25 CN-stable individuals. Results: AD-signature cortical thinning in CN-AD converters in both samples was remarkably similar, about 0.2 mm (p < 0.05). Despite this small absolute difference, Cohen d effect sizes for these differences were very large (>1). Of the 11 CN individuals with baseline low AD-signature thickness (≥1 SD below cohort mean), 55% developed AD dementia over nearly the next decade, while none of the 9 high AD-signature thickness individuals (≥1 SD above mean) developed dementia. This marker predicted time to diagnosis of dementia (hazard ratio = 3.4, p < 0.0005); 1 SD of thinning increased dementia risk by 3.4. Conclusions: By focusing on cortical regions known to be affected in AD dementia, subtle but reliable atrophy is identifiable in asymptomatic individuals nearly a decade before dementia, making this measure a potentially important imaging biomarker of early neurodegeneration.Keywords
This publication has 42 references indexed in Scilit:
- Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controlsNeuroImage, 2010
- Cognition, reserve, and amyloid deposition in normal agingAnnals of Neurology, 2010
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer DiseaseArchives of Neurology, 2009
- Longitudinal Study of the Transition From Healthy Aging to Alzheimer DiseaseArchives of Neurology, 2009
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- Alzheimer Disease and Cognitive ReserveArchives of Neurology, 2008
- Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normalNeurobiology of Aging, 2008
- Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairmentNeurobiology of Aging, 2008
- Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengthsNeuroImage, 2007
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991